We provide the first evidence that JMJD3 epigenetically regulates the expression levels of syntenin via H3K27me3 demethylation, leading to TGF-β1-induced Smad2/3 activation and EMT in lung cancer cells. Here, SMAD2 is linked to lung cancer.